0001178913-22-001024.txt : 20220309
0001178913-22-001024.hdr.sgml : 20220309
20220309160713
ACCESSION NUMBER: 0001178913-22-001024
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220307
FILED AS OF DATE: 20220309
DATE AS OF CHANGE: 20220309
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nicaise Claude
CENTRAL INDEX KEY: 0001644162
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38807
FILM NUMBER: 22725448
MAIL ADDRESS:
STREET 1: 215 FIRST STREET, SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Chemomab Therapeutics Ltd.
CENTRAL INDEX KEY: 0001534248
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813676773
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: KIRYAT ATIDIM, BUILDING 7
CITY: TEL AVIV
STATE: L3
ZIP: 6158002
BUSINESS PHONE: 972-77-331-0156
MAIL ADDRESS:
STREET 1: KIRYAT ATIDIM, BUILDING 7
CITY: TEL AVIV
STATE: L3
ZIP: 6158002
FORMER COMPANY:
FORMER CONFORMED NAME: Anchiano Therapeutics Ltd.
DATE OF NAME CHANGE: 20180906
FORMER COMPANY:
FORMER CONFORMED NAME: BioCancell Ltd.
DATE OF NAME CHANGE: 20111104
4
1
zk2227456.xml
X0306
4
2022-03-07
0
0001534248
Chemomab Therapeutics Ltd.
CMMB
0001644162
Nicaise Claude
319 REDSTONE DRIVE
CHESHIRE
CT
06410
1
0
0
0
Option to Purchase American Depositary Shares
3.53
2022-03-07
4
A
0
6820
0
A
2032-03-07
American Depositary Shares
6820
6820
D
Option to Purchase American Depositary Shares
27.26
2021-04-19
4
A
0
11884
0
A
2031-04-19
American Depositary Shares
11884
11884
D
These options vest and become exercisable in their entirety on March 16, 2023.
Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service.
/s/ Matthew Rudolph, Esq., Attorney-in-Fact for Claude Nicaise
2022-03-09